Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

EOS imaging

BATS-CHIXE:EOSIP
Snowflake Description

Limited growth with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EOSIP
BATS-CHIXE
€58M
Market Cap
  1. Home
  2. GB
  3. Healthcare
Company description

EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. The last earnings update was 196 days ago. More info.


Add to Portfolio Compare Print
  • EOS imaging has significant price volatility in the past 3 months.
EOSIP Share Price and Events
7 Day Returns
3.3%
BATS-CHIXE:EOSIP
-1.2%
GB Medical Equipment
0.1%
GB Market
1 Year Returns
22.7%
BATS-CHIXE:EOSIP
-0.3%
GB Medical Equipment
-23.6%
GB Market
EOSIP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
EOS imaging (EOSIP) 3.3% -16.7% -23.3% 22.7% -54.6% -56.2%
GB Medical Equipment -1.2% -12% -19.1% -0.3% -2.3% 20.9%
GB Market 0.1% -15.5% -27% -23.6% -24.3% -23.5%
1 Year Return vs Industry and Market
  • EOSIP outperformed the Medical Equipment industry which returned -0.3% over the past year.
  • EOSIP outperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -23.6% over the past year.
Price Volatility
EOSIP
Industry
5yr Volatility vs Market

EOSIP Value

 Is EOS imaging undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for EOS imaging. This is due to cash flow or dividend data being unavailable. The share price is €2.17.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for EOS imaging's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are EOS imaging's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:EOSIP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in EUR €-0.69
ENXTPA:EOSI Share Price ** ENXTPA (2020-04-06) in EUR €2.19
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PE Ratio Median Figure of 11 Publicly-Listed Medical Equipment Companies 25.55x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 12.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of EOS imaging.

BATS-CHIXE:EOSIP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:EOSI Share Price ÷ EPS (both in EUR)

= 2.19 ÷ -0.69

-3.16x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EOS imaging is loss making, we can't compare its value to the GB Medical Equipment industry average.
  • EOS imaging is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does EOS imaging's expected growth come at a high price?
Raw Data
BATS-CHIXE:EOSIP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.16x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
45%per year
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PEG Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 2x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 517 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for EOS imaging, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on EOS imaging's assets?
Raw Data
BATS-CHIXE:EOSIP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in EUR €0.75
ENXTPA:EOSI Share Price * ENXTPA (2020-04-06) in EUR €2.19
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PB Ratio Median Figure of 20 Publicly-Listed Medical Equipment Companies 2.83x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.11x
BATS-CHIXE:EOSIP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:EOSI Share Price ÷ Book Value per Share (both in EUR)

= 2.19 ÷ 0.75

2.9x

* Primary Listing of EOS imaging.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EOS imaging is overvalued based on assets compared to the GB Medical Equipment industry average.
X
Value checks
We assess EOS imaging's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. EOS imaging has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EOSIP Future Performance

 How is EOS imaging expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
45%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is EOS imaging expected to grow at an attractive rate?
  • Unable to compare EOS imaging's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare EOS imaging's earnings growth to the United Kingdom of Great Britain and Northern Ireland market average as it is expected to be loss making during the next 1-3 years.
  • EOS imaging's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:EOSIP Future Growth Rates Data Sources
Data Point Source Value (per year)
BATS-CHIXE:EOSIP Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 45%
BATS-CHIXE:EOSIP Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 32%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.1%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.5%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:EOSIP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:EOSIP Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 52 -2 -5 2
2020-12-31 41 -7 -10 2
2020-04-07
2019-12-31 27 -16 -18 2
BATS-CHIXE:EOSIP Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-06-30 26 -9 -17
2019-03-31 31 -9 -15
2018-12-31 37 -9 -13
2018-09-30 38 -12 -11
2018-06-30 40 -14 -10
2018-03-31 39 -12 -9
2017-12-31 39 -10 -8
2017-09-30 37 -7 -8
2017-06-30 35 -4 -7
2017-03-31 34 -4 -7
2016-12-31 33 -3 -6
2016-09-30 30 -6 -7

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • EOS imaging is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • EOS imaging's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:EOSIP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from EOS imaging Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:EOSIP Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 -0.17 -0.10 -0.25 2.00
2020-12-31 -0.36 -0.28 -0.43 2.00
2020-04-07
2019-12-31 -0.64 -0.63 -0.66 2.00
BATS-CHIXE:EOSIP Past Financials Data
Date (Data in EUR Millions) EPS *
2019-06-30 -0.69
2019-03-31 -0.63
2018-12-31 -0.57
2018-09-30 -0.50
2018-06-30 -0.44
2018-03-31 -0.40
2017-12-31 -0.36
2017-09-30 -0.34
2017-06-30 -0.36
2017-03-31 -0.30
2016-12-31 -0.30
2016-09-30 -0.32

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if EOS imaging will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.
X
Future performance checks
We assess EOS imaging's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
EOS imaging has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EOSIP Past Performance

  How has EOS imaging performed over the past 5 years?

  • EOS imaging's last earnings update was 196 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare EOS imaging's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • EOS imaging does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare EOS imaging's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare EOS imaging's 1-year growth to the GB Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
EOS imaging's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from EOS imaging Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:EOSIP Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 25.52 -17.17 22.50 4.81
2019-03-31 31.17 -15.10 22.38 4.62
2018-12-31 36.82 -13.04 22.26 4.43
2018-09-30 38.33 -11.47 21.64 4.22
2018-06-30 39.84 -9.91 21.02 4.02
2018-03-31 39.32 -8.85 20.23 4.06
2017-12-31 38.81 -7.79 19.45 4.10
2017-09-30 36.94 -7.64 18.81 4.10
2017-06-30 35.07 -7.49 18.18 4.10
2017-03-31 34.08 -6.83 17.53 3.99
2016-12-31 33.10 -6.17 16.88 3.89
2016-09-30 30.45 -6.57 16.04 3.85
2016-06-30 27.81 -6.97 15.20 3.82
2016-03-31 25.73 -7.07 14.76 3.78
2015-12-31 23.66 -7.18 14.33 3.74
2015-09-30 24.21 -5.57 14.08 3.48
2015-06-30 24.76 -3.96 13.84 3.22
2015-03-31 23.24 -4.60 13.61 3.21
2014-12-31 21.72 -5.25 13.39 3.21
2014-09-30 20.47 -5.91 12.82 3.27
2014-06-30 19.22 -6.57 12.26 3.32
2014-03-31 17.95 -6.23 11.72 2.96
2013-12-31 16.67 -5.88 11.18 2.60
2013-09-30 14.90 -5.96 10.30 2.23
2013-06-30 13.12 -6.04 9.41 1.86

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if EOS imaging has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if EOS imaging has efficiently used its assets last year compared to the GB Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if EOS imaging improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess EOS imaging's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
EOS imaging has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EOSIP Health

 How is EOS imaging's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up EOS imaging's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • EOS imaging is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • EOS imaging's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of EOS imaging's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from EOS imaging Company Filings, last reported 9 months ago.

BATS-CHIXE:EOSIP Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 19.79 26.98 8.69
2019-03-31 19.79 26.98 8.69
2018-12-31 29.21 27.26 19.77
2018-09-30 29.21 27.26 19.77
2018-06-30 21.12 27.81 8.87
2018-03-31 21.12 27.81 8.87
2017-12-31 23.20 15.78 6.93
2017-09-30 23.20 15.78 6.93
2017-06-30 27.30 18.29 17.57
2017-03-31 27.30 18.29 17.57
2016-12-31 22.77 18.76 14.91
2016-09-30 22.77 18.76 14.91
2016-06-30 25.55 17.50 14.43
2016-03-31 25.55 17.50 14.43
2015-12-31 27.77 12.84 14.09
2015-09-30 27.77 12.84 14.09
2015-06-30 23.55 8.38 6.35
2015-03-31 23.55 8.38 6.35
2014-12-31 25.46 3.54 10.15
2014-09-30 25.46 3.54 10.15
2014-06-30 26.31 4.28 13.70
2014-03-31 26.31 4.28 13.70
2013-12-31 30.07 8.92 20.75
2013-09-30 30.07 8.92 20.75
2013-06-30 28.90 0.91 21.68
  • EOS imaging's level of debt (136.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (16.3% vs 136.4% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on EOS imaging's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess EOS imaging's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. EOS imaging has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EOSIP Dividends

 What is EOS imaging's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from EOS imaging dividends. Estimated to be 0% next year.
If you bought €2,000 of EOS imaging shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate EOS imaging's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate EOS imaging's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:EOSIP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2.2%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.6%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.6%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:EOSIP Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 0.00 1.00
2020-12-31 0.00 1.00
2020-04-07
2019-12-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as EOS imaging has not reported any payouts.
  • Unable to verify if EOS imaging's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of EOS imaging's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as EOS imaging has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of EOS imaging's dividends in 3 years as they are not expected to pay a notable one for United Kingdom of Great Britain and Northern Ireland.
X
Income/ dividend checks
We assess EOS imaging's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can EOS imaging afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. EOS imaging has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EOSIP Management

 What is the CEO of EOS imaging's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mike Lobinsky
COMPENSATION €0
TENURE AS CEO 1.3 years
CEO Bio

Mr. Mike Lobinsky is Chief Executive Officer of EOS imaging SA since January 1, 2019 and serves as its Director. He was President of North America at EOS imaging SA since joining in August 2017 until December 31, 2018. He has over twenty years’ experience in the medtech industry with senior management roles in sales, marketing, operations and business development in the fields of Orthopedic Robotics, Navigation, Imaging and Implants. He served as Vice President of Sales of Blue Belt Technologies, Inc. Mr. Lobinsky served as Vice President of Sales for East Region at Blue Belt Technologies, Inc. since February 2013. Mr. Lobinsky has over 16 years of experience in the medical device industry. He is experienced in building and managing successful sales, marketing and clinical organizations and in the market development of new and innovative products. He served as Vice President of Sales and Marketing at Biomedix Inc. Mr. Lobinsky was responsible for building and directing a national sales force who use consultative selling skills to help healthcare providers build vascular centers of excellence for Biomedix Inc. He designs and implements systems which ensure that there is alignment between company and sales professionals goals. Mr. Lobinsky held Director level sales management positions in the fields of Orthopedics, Neurosurgery, and Medical Imaging. He served as Regional Sales Manager of Stryker Corporation. He has held leadership positions at Smith and Nephew, Brainlab, Mr. Lobinsky received a BA from University of Wisconsin-River Falls.

CEO Compensation
  • Insufficient data for Mike to compare compensation growth.
  • Insufficient data for Mike to establish whether their remuneration is reasonable compared to companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure of the EOS imaging management team in years:

1.3
Average Tenure
  • The average tenure for the EOS imaging management team is less than 2 years, this suggests a new team.
Management Team

Mike Lobinsky

TITLE
CEO & Director
TENURE
1.3 yrs

Valérie Worrall

TITLE
Chief Financial Officer
TENURE
1.4 yrs

Eric Maulavé

TITLE
Chief Operating Officer
TENURE
2.5 yrs

Carl Denys

TITLE
Vice President of Global Marketing
TENURE
0.3 yrs

Helene Roty

TITLE
Director of Human Resources
TENURE
0.3 yrs

Elisabeth Soubelet

TITLE
Chief Medical Officer
TENURE
4.7 yrs

Maurice Delplanque

TITLE
Vice President of Engineering

Youcef Imoussaine

TITLE
Field Maintenance Director
Board of Directors Tenure

Average tenure and age of the EOS imaging board of directors in years:

6.3
Average Tenure
68
Average Age
  • The tenure for the EOS imaging board of directors is about average.
Board of Directors

Gérard Hascoët

TITLE
Chairman of the Board
COMPENSATION
€65K
AGE
70
TENURE
4.8 yrs

Mike Lobinsky

TITLE
CEO & Director

Marie-Laure Garrigues

TITLE
Director
TENURE
8.3 yrs

Eric Beard

TITLE
Independent Director
COMPENSATION
€30K
AGE
68
TENURE
7.8 yrs

Marie Meynadier

TITLE
Director
COMPENSATION
€683K
AGE
58

Antoine Vidal

TITLE
Director
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by EOS imaging individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
23. Mar 20 Sell Jeffrey Black Individual 10. Mar 20 10. Mar 20 -6,563 €4.49 €-29,439
23. Mar 20 Buy Patrick Miles Individual 17. Mar 20 17. Mar 20 77,500 €3.00 €232,500
23. Mar 20 Sell James L. Tullis Individual 13. Mar 20 17. Mar 20 -75,000 €3.51 €-232,860
23. Mar 20 Buy Brian Snider Individual 11. Mar 20 11. Mar 20 45,000 €3.98 €178,880
23. Mar 20 Buy David Sponsel Individual 11. Mar 20 11. Mar 20 11,000 €4.00 €44,019
13. Mar 20 Buy Oddo Bhf Asset Management SAS Company 12. Mar 20 12. Mar 20 10,000 €2.28 €22,800
05. Mar 20 Buy Oddo Bhf Asset Management SAS Company 04. Mar 20 04. Mar 20 25,000 €2.66 €66,500
04. Mar 20 Buy Oddo Bhf Asset Management SAS Company 03. Mar 20 03. Mar 20 281,718 €2.70 €760,638
03. Mar 20 Buy Oddo Bhf Asset Management SAS Company 02. Mar 20 02. Mar 20 993,282 €2.69 €2,671,928
X
Management checks
We assess EOS imaging's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. EOS imaging has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EOSIP News

Simply Wall St News

EOSIP Company Info

Description

EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, an imaging system that provides low dose, full body, and stereo-radiographic images of patient in a functional position; EOSedge, an X-ray system that provides images quality for patients; sterEOS, a 3D modeling workstation that analyzes frontal and lateral EOS images which are captured simultaneously and registered to generate precise, patient-specific, and 3D models of the spine and/or lower limbs from weight-bearing, low dose, or Micro Dose EOS exams; and EOSapps, an online 3D surgical planning solutions based on unbiased, weight-bearing EOS images, and an accurate 2D/3D patient-specific data set. The company also provides 3D surgical planning software and patient-specific instruments for hip and knee arthroplasties. It sells its products in Europe, the Middle East, Africa, North Africa, and the Asia-Pacific. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS imaging SA was founded in 1989 and is headquartered in Paris, France.

Details
Name: EOS imaging SA
EOSIP
Exchange: BATS-CHIXE
Founded: 1989
€58,029,759
26,497,607
Website: http://www.eos-imaging.com
Address: EOS imaging SA
10 rue Mercœur,
Paris,
Ile-de-France, 75011,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA EOSI Common Stock Euronext Paris FR EUR 16. Feb 2012
OTCPK EOSG.F Common Stock Pink Sheets LLC US USD 16. Feb 2012
LSE 0QAR Common Stock London Stock Exchange GB EUR 16. Feb 2012
BATS-CHIXE EOSIP Common Stock BATS 'Chi-X Europe' GB EUR 16. Feb 2012
Number of employees
Current staff
Staff numbers
174
EOS imaging employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 19:58
End of day share price update: 2020/04/06 00:00
Last estimates confirmation: 2020/03/27
Last earnings filing: 2019/09/24
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.